📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ESSA Pharma

1.1 - Company Overview

ESSA Pharma Logo

ESSA Pharma

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small molecule drugs for cancer treatment, with a focus on advanced prostate cancer, developing therapies that selectively block the N-terminal domain of the androgen receptor, a target required for the growth and survival of most prostate cancers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ESSA Pharma

Zionexa Logo

Zionexa

HQ: United States Website
  • Description: Provider of in-vivo biomarkers developed and commercialized to guide targeted therapies in oncology, aiming to improve patients' pathway and quality of life.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zionexa company profile →
Theranostics Health Logo

Theranostics Health

HQ: United States Website
  • Description: Provider of proteomics-based diagnostics and research services for drug development companies, developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor, utilizing Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theranostics Health company profile →
BioNovion Logo

BioNovion

HQ: United States Website
  • Description: Provider of immune oncology antibody discovery and development focused on antibodies for the immune therapy of cancer; U.S.-based, founded in 2011 and acquired by Aduro BioTech in 2015.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioNovion company profile →
Ceptaris Logo

Ceptaris

HQ: United States Website
  • Description: Provider of a proprietary gel formulation of mechlorethamine hydrochloride under development for the treatment of early-stage (stages I–IIA) mycosis fungoides, a type of cutaneous T-cell lymphoma (CTCL); if approved, it would be the first topical treatment for this indication.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ceptaris company profile →
Guided Therapeutics Logo

Guided Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Guided Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ESSA Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ESSA Pharma

2.2 - Growth funds investing in similar companies to ESSA Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ESSA Pharma

4.2 - Public trading comparable groups for ESSA Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ESSA Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ESSA Pharma

What does ESSA Pharma do?

ESSA Pharma is a provider of small molecule drugs for cancer treatment, with a focus on advanced prostate cancer, developing therapies that selectively block the N-terminal domain of the androgen receptor, a target required for the growth and survival of most prostate cancers.

Who are ESSA Pharma's competitors?

ESSA Pharma's competitors and similar companies include Zionexa, Theranostics Health, BioNovion, Ceptaris, and Guided Therapeutics.

Where is ESSA Pharma headquartered?

ESSA Pharma is headquartered in Canada.

How many employees does ESSA Pharma have?

ESSA Pharma has 1,000 employees 🔒.

When was ESSA Pharma founded?

ESSA Pharma was founded in 2010 🔒.

What sector and industry vertical is ESSA Pharma in?

ESSA Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ESSA Pharma

Who are the top strategic acquirers in ESSA Pharma's sector and industry

Top strategic M&A buyers and acquirers in ESSA Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ESSA Pharma?

Top strategic M&A buyers groups and sectors for ESSA Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ESSA Pharma's sector and industry vertical

Which are the top PE firms investing in ESSA Pharma's sector and industry vertical?

Top PE firms investing in ESSA Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ESSA Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ESSA Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ESSA Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ESSA Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ESSA Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ESSA Pharma?

The key public trading comparables and valuation benchmarks for ESSA Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ESSA Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ESSA Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ESSA Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ESSA Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ESSA Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in ESSA Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ESSA Pharma

Launch login modal Launch register modal